Non-melanoma skin cancer development and environmental factors

• Autorzy: Narbutt J , Lesiak A. , Erkiert A. , Sysa-Jedrzejowska A.
• Języki publikacji: EN

Abstrakty

EN

Multiple and interacting environmental factors are involved in the development of non-melanoma skin cancers (NMSC) in the Caucasian population. NMSC include basal cell carcinomas and squamous cell skin carcinoma. The aim of our paper was to present literature data on the etiopathogenesis of NMSC with special stress on environmental agents such as: ultraviolet radiation (including sunbathing), ozone depletion, smoking and occupational factors. The role of administered treatment with phototherapy and immunosuppresants is described as well. As skin cancer incidence has increased, the necessity of avoidance of NMSC risk factors is highlighted.

Słowa kluczowe

EN

basal cell carcinoma; skin; environmental factor; non-melanoma cancer; cancer development; Caucasian population; occupational factor; ultraviolet radiation; skin cancer

• Wydawca: -
• Czasopismo: Polish Journal of Environmental Studies
• Rocznik: 2005
• Tom: 14
• Numer: 5
• Opis fizyczny: p.545-550,ref.

Twórcy

autor

Narbutt J

• Medical University of Lodz, Krzemieniecka 5, 94-017 Lodz, Poland

autor

Lesiak A.

autor

Erkiert A.

autor

Sysa-Jedrzejowska A.

Bibliografia

• 1. DIEPGEN T. L., MAHLER V. The epidemiology of skin cancer. Br. J. Dermatol. 146, 1, 2002.
• 2. BOWER C. P. R., LEAR J. T., BYGRAVE S., ETHERINGTON D., HARVEY I., ARCHER C. B. Basal cell carcinoma and risk of subsequent malignancies: A cancer registrybased study in southwest England. J. Am. Acad. Dermatol. 42, 988, 2000.
• 3. MATTA J. L., VILLA J. L., ROMOS J. M., SANCHES J., CHOMPRE G., RUIZ A., GROSSMAN L. DNA repair and nonmelanoma skin cancer in Puerto Rican populations. J. Am. Acad. Dermatol. 49,433, 2003.
• 4. KARAGAS M. R., GREENBERG E. R., SPENCER S. K., STUKEL T. A., MOTT L. A. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. Int. J. Cancer 81, 555, 1999.
• 5. HOLME S. A., MALINOVSZKY K., ROBERTS D. L. Changing trends in non-melanoma skin cancer in South Wales, 1988-98. Br. J. Dermatol. 143, 1224, 2000.
• 6. WEINSTOCK M. A. Nonmelanoma skin cancer mortality in the United States, 1969 through 1988. Arch. Dermatol. 129, 1286, 1993.
• 7. LACOUR J. P. Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms. Br. J. Dermatol. 146, 17, 2002.
• 8. NALDI L., DILANDRO A., D’AVANZO B., PARAZZINI F. Host-related and environmental risk factors for cutaneous basal cell carcinoma: evidence from an Italian case-control study. J. Am. Acad. Dermatol. 42, 446, 2000.
• 9. MILAN T., VERKASALO P. K., KAPRIO J., KOSKENVUO M., PUKKALA E. Malignant skin cancers in the Finnish Twin Cohort: a population-based study, 1976-97. Br. J. Dermatol. 147, 509, 2002.
• 10. RIGEL E. G., LEBOWHL M. G., RIGEL A. C., RIGEL D. S. Ultraviolet Radiation in Alpine Skiing. Arch. Dermatol. 139, 60, 2003.
• 11. HEMMINKI K., XU G., KAUSE L., KOULU L. M., ZHAO C., JANSEN C. T. Demonstration of UV-dimers in human skin DNA in situ 3 weeks after exposure. Carcinogenesis 23, 605, 2002.
• 12. HECKMANN M., ZOGELMEIER F., KONZ B. Frequency of facial basal cell carcinoma does not correlate with sitespecific UV exposure. Arch. Dermatol. 138, 1494, 2002.
• 13. LEMAN J. A., MCHENRY P. M. Basal cell carcinoma. Arch. Dermatol. 137, 1239, 2001.
• 14. BRASH D. E., RUDOLPH J. A., SIMON J. A., LIN A., MCKENNA G. J., BADEN H. P., HALPERIN A. J., PONTEN J. A role for sunlight in s cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 88, 10124, 1991.
• 15. ZIEGLER A., LEFFELL D. J., KUNALA S., SHARMA H. W., GAILANI M., SIMON J. A., HALPERIN A. J., BADEN H. P., SHAPIRO P. E., BALE A. E. Mutations hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc. Natl. Acad. Sci. USA 90, 4216, 1993.
• 16. KO L. J., PRIVES C. p53 puzzle and paradigm. Genes Dev. 266, 1954, 1996.
• 17. FORD J. M., NANAWALT P. C. Expression of wild type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts. J. Biol. Chem. 272, 28073, 1997.
• 18. LANE D. P. Cancer, p53 guardian of the genome. Nature 358, 15, 1992.
• 19. GAILANI M. R., LEFFELL D. J., ZIEGLER A. M., GROSS E. G., BRASH D. E., BALE A. E. Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma. J. Natl. Cancer Inst. 88, 349, 1996.
• 20. RATNER D., PEACOCKE M., ZHANG H., PING X. L., TSOU H. C. UV-specific p53 and PTCH mutations in sporadic basal cell carcinoma of sun-exposed skin. J. Am. Acad. Dermatol. 44, 293, 2001.
• 21. CORONA R., DOGLIOTTI E., D’ERRICO M., SERA F., IAVANORE I., BALIVE G., CHINNI L. M., GOBELLO T., MAZZANTI C., PUDDU P., PASQUINI P. Risk factors for basal cell carcinoma in a Mediterranean Population. Arch. Dermatol. 137, 1162, 2001.
• 22. GALLAGHER R. P., HILL G. B., BAJDIK C. D., FINCHAM S., COLDMAN A., MCLEAN D. I., THRELFALL W. J. Sunlight exposure, pigmentary factors and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch. Dermatol. 131, 157, 1995.
• 23. VLAJINAC H. D., ADANJA B. J., LAZAR Z. F., BAGOVAC A. N., BJEKIĆ M. D., MARKOVIĆ J. M., KOCEV N. I. Risk factors for basal cell carcinoma. Acta Oncologica 39, 611, 2000.
• 24. ZANETTI R., ROSSO S., MARTINEZ C., NAVARR C., SCHRAUB S., SANCHO-GARNIER H., FRANCESCHI S., GAFA L., PEREA E., TORMO M. J., LAURENT R., SCHRAMECK C., CRISTOFOLINI M., TUMINO R., WECHLER J. The multicentre south European study “Helios”I: skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin. Br. J. Cancer 73, 1440, 1996.
• 25. LIM H. W., COOPER K. The health impact of solar radiation and prevention strategies. J. Am. Acad. Dermatol. 41, 81, 1999.
• 26. SOLOMOM S. The hole truth. What’s news (and what’s not) about the ozone hole. Nature 427, 289, 2004.
• 27. MADRONICH S., DE GRUIJL F. R. Stratospheric ozone depletion between 1979 and 1992: implications for biologically active ultraviolet-B radiation and non-melanoma skin cancer incidence. Photochem. Photobiol. 59, 541, 1994.
• 28. MOAN J., DAHLBACK A., HENRIKSEN T., MAGNUS K. Biological amplification factors for sunlight – induced nonmelanoma skin cancer at high latitudes Cancer Res. 49, 5207, 1989.
• 29. WESTER U., BOLDEMANN C., JANSSON B., ULLEN H. Population UV-dose and skin area – do sunbeds rival the sun? Health. Phys. 77, 436, 1999.
• 30. BOYD A. S., SHYR Y., KING L. E. Basal cell carcinoma in young women: An evaluation of the association of tanning bed use and smoking. J. Am. Acad. Dermatol. 46, 706, 2002.
• 31. WHITMORE S. E., MORISON W. L., POTTEN C. S., CHADWICK C. Tanning salon exposure and molecular alterations. J. Am. Acad. Dermatol. 44, 775, 2001.
• 32. DIFFEY B. L. Analysis of the risk of sun skin cancer from sunlight and solaria in subjects living in northern Europe. Photodermatology 4, 118, 1987.
• 33. OTLEY C. C. Immunosuppression and skin cancer. Arch. Dermatol. 38, 827, 2002.
• 34. BERG D., OTLEY C. C. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis and management. J. Am. Acad. Dermatol. 47, 1, 2002.
• 35. RAMSAY H. M., FRYER A. A., HAWLEY C. M., SMITH A. G., NICOL D. L., HARDEN P. N. Non-melanoma skin cancer risk in the Queensland renal transplant population. Br. J. Dermatol. 147, 950, 2002.
• 36. HARVELT M. M., BAVINCK J. N., KOOTTE A. M., VERMEER B. J., VANDENBROUCKE J. P. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 49, 506, 1990.
• 37. RAMSAY H. M., FRYER A. A., HAWLEY C. M., SMITH A. G., NICOL D. L., HARDEN N. Factors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia. J. Am. Acad. Dermatol. 49, 397, 2003.
• 38. LINDELÖF B., SIGURGEIRSSON B., GÄBEL H., STERN R. S. Incidence of skin cancer in 5356 patients following organ transplantation. Br. J. Dermatol. 143, 513, 2000.
• 39. KASISKE B. L., VAZQUEZ M. A., HARMON W. E. Recommendations for the outpatient surveillance of renal transplant recipients. J. Am. Soc. Nephrol. 11, S1, 2000.
• 40. MAIER H., SCHEMPER M., ORTEL B., BINDER M., TANEW A., HÖNIGSMANN H. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients. Dermatology 193, 185, 1996.
• 41. HANNUKSELA-SVAHN A., PUKKALA E., KOULU L., JANSEN C. T., KARVONEN J. Cancer incidence among Finnish psoriasis patients treated with 8-methoxxypsoralen bath PUVA. J. Am. Acad. Dermatol. 40, 694, 1999.
• 42. SEIDL H., KREIMER-ERLACHER H., BACK B., SOYER H. P., HOFLER G., KERL H. WOLF P. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis. J. Invest. Dermatol. 117, 1688, 2001.
• 43. STERN R. S., LIEBMAN E. J., VAKEVA L. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA followup study. J. Natl. Cancer Inst. 90, 1278, 1998.
• 44. DE GRUIJL F. R. Photocarcinogenesis UVA vs. UVB radiation. Skin Pharmacol. Appl. Skin Physiol. 15 (5), 316, 2002.
• 45. DE HERTOG S. A., WENSTEN C. A., BASTIAENS M. T., KIELICH C. J., BERKHOUT M., WESTENDORP R. G., VERMEER B. J., BOUWES BAVINCK J. N. Relation between smoking and skin cancer. J. Clin. Oncol. 19 (1), 231, 2001.
• 46. AUBRY F., MACGIBBON B. Risk factors of squamous cell carcinoma of the skin: a case-control study in the Montreal region. Cancer 55, 907, 1985.
• 47. VAN DAM R. M., HUANG Z., RIMM E. B., WEINSTOCK M. A., SPIEGELMAN D., COLDITZ G. A., WILLETT W. C., GIOVANNUCCI E. Risk factors for basal cell carcinoma of the skin in men: results from the health professionals follow-up study. Am. J. Epidemiol. 150, 459, 1999.
• 48. WOJNO T. H. The association between cigarette smoking and basal cell carcinoma of the eyelids in women. Ophtal. Plast. Reconstr. Surg. 15, 390, 1999.
• 49. SMITH J. B., RANDLE H. W. Giant basal cell carcinoma and cigarette smoking. Cutis 67, 73, 2001.
• 50. ERBAGCI Z., ERKILIC S. Can smoking and/or occupational UV exposure have any role in the development of the morheaphorm basal cell carcinoma? A critical role for paritumoral mast cells. Int. J. Dermatol. 41, 275, 2002.
• 51. LEI U., MASMAS T. N., FRENTZ G. Occupational nonmelanoma skin cancer. Acta Derma. Venereol. 81,415, 2001.
• 52. LETZEL S., DREXLER H. Occupationally related tumors in tar refinery workers. J. Am. Acad. Dermatol. 39, 712, 1998.
• 53. GALLAGHER R. P., BAJDIK C. D., FINCHAM S. Chemical exposures, medical history, and risk of squamous and basal cell carcinoma of the skin. Cancer. Epidemiol. Biomarkers. Prev. 5, 419, 1996.
• 54. ZIGLER V., NAGEL U., KOHLSTEDT A., WINIECKI P. Occupationally-induced skin tumors in East Germany. Increased risk of basalioma in furriers and hide processors? Dermatol. Monatsschr. 175, 76, 1989.
• 55. BOONCHAI W., WALSH M., CUMMINGS M., CHENEVIX-TRENCH G. Expression of p53 in arsenic-related and sporadic basal cell carcinoma. Arch. Dermatol. 136, 195, 2000.
• 56. KARAGAS M. R., STUKEL T. A., MORRIS J. S., TOSTESON T. D., WEISS J. E., SPENCER S. K., GREENBERG E. R. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am. J. Epidemiol. 153, 559, 2001.
• 57. TSENG W. P., CHUR H. M., HOW S. W. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 40, 453, 1968.
• 58. NEUBAUER O. Arsenical cancer: a review. Br. J. Cancer 1, 192, 1947.
• 59. BOONCHAI W., GREEN A., NG J., DICKER A., CHENEVIX-TRENCH G. Basal cell carcinoma in chronic arsenicism occurring in Queensland, Australia, after ingestion of an asthma medication. J. Am. Acad. Dermatol. 43, 664, 2000.
• 60. LICHTER M. D., KARAGAS M. R., MOTT L. A., SPENCER S. K., STUKEL T. A., GREENBERG E. R. Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. Arch. Dermatol. 136, 1007, 2000.
• 61. SHORE R. E. Radiation-induced skin cancer in humans. Med. Pediatr. Oncol. 36, 549, 2001.
• 62. STEINERT M., WEISS M., GOTTLÖBER P., BELYI D., GERGEL O., BEBESHO V., NADEJINA N., GALSTIAN I., WAGEMAKER G., FLIEDNER T. M., PETER R. U. Delyed effects of accidental cutaneous radiation exposure: Fifteen years of follow-up after the Chernobyl accident. J. Am. Acad. Dermatol. 49, 417, 2003.
• 63. RON E., PRESTON D. L., KISHIKAWA M. Skin tumor risk among atomic-bomb survivors in Japan. Cancer Causes. Control. 9, 393, 1998.
• 64. GLOSTER H. M., BRODLAND D. G. The epidemiology of skin cancer. Dermatol. Surg. 22, 217, 1996.